# Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation

> **NCT01262417** · PHASE2 · COMPLETED · sponsor: **Centre Leon Berard** · enrollment: 60 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **PROCEDURE:** - use of resorbable membrane Seprafilm
- **PROCEDURE:** without resorbable barrier (seprafilm)

## Key facts

- **NCT ID:** NCT01262417
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-11
- **Final completion:** —
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2010-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01262417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01262417, "Resorbable Barrier for the Prevention of Abdominal and Peri-hepatic Adhesion Formation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01262417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*